In this final episode of Season 1, we discuss how the COVID-19 pandemic has impacted strategies to address antimicrobial resistance. Our guests will describe the patient experience of surviving COVID, the role of antimicrobial stewardship in managing COVID patients, and how the COVID-19 pandemic potentiates AMR and emerging approaches to the surveillance, treatment and prevention of AMR.

Learn more about our guests this week:

Dr. Marilyn Stebbins:
https://pharmacy.ucsf.edu/news/2020/04/my-covid-19-journey

Dr. Ryan Stevens:
https://www.idstewardship.com/contributors/ryan-stevens-pharm-d-bcps-bcidp/

Dr. Manica Balasegaram:
https://gardp.org/team/manica-balasegaram/

This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition (ARFC).

This podcast is available on Apple Podcasts, Spotify, and Google Podcasts.

Infections caused by highly drug-resistant bacteria, or “superbugs,” are becoming more and more common, making antimicrobial resistance one of the world’s greatest health threats. In fact, infections caused by superbugs are projected to reach epidemic levels within our lifetimes. Drug-resistant infections can affect anyone, and we are all at risk.

This podcast series will address this global crisis through conversations with patients, clinicians, and researchers to discover how superbugs are affecting people and healthcare systems globally. And we’ll highlight actions the average citizen can take today to make sure the drugs we already have stay effective, in order to protect ourselves, our families, and our communities.